| Literature DB >> 7528354 |
R A Sobel1, J M Greer, V K Kuchroo.
Abstract
The authors present a brief historical sketch of the development of our understanding of immune responses to myelin proteolipid protein (PLP) and the acceptance of PLP as a potent antigen in the induction of experimental allergic encephalomyelitis (EAE). The distinct characteristics of the PLP molecule that may contribute to complex immune responses to this protein are reviewed and these responses are compared with those to MBP, both in the pathology of EAE and at the level of the T cell. Recent evidence demonstrating differences between T cell responses to PLP and MBP is reviewed. Finally, the potential contribution of immune responses to PLP in human diseases, particularly multiple sclerosis (MS), that have been identified to date are then summarized.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7528354 DOI: 10.1007/bf00968701
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996